Why is Torrent Pharma falling/rising?

As of 06-Aug, Torrent Pharmaceuticals Ltd. is experiencing a decline in its stock price, currently at Rs 3,519.85, which reflects a decrease of Rs 69.25 or 1.93%. The stock has been on a downward trend, losing value for the last four consecutive days, resulting in a total decline of 6.42% during this period. Today's performance aligns with the sector, which has also seen a decrease of 2.17%. Despite the recent downturn, the company has shown strong financial metrics, including a high return on capital employed (ROCE) of 22.33% and a low debt to EBITDA ratio of 1.26 times, indicating solid management efficiency and debt servicing capability. Additionally, the company has reported positive results for the last eight consecutive quarters, which may provide some support to the stock despite the current price drop.
In the broader market context, Torrent Pharmaceuticals' short-term performance has been notably weaker than the benchmark, with a 1-week return of -5.76% compared to the Sensex's decline of only -1.15%. This underperformance in the short term contrasts with the stock's stronger returns over longer periods, such as a 9.52% increase over the past year, which outperformed the Sensex's 2.48% gain. The recent fall in investor participation, with a significant drop in delivery volume, may also be contributing to the stock's current decline, reflecting a cautious sentiment among investors in the pharmaceuticals sector.